• Stephen F Kingsmore, Darrell L Dinwiddie, Neil A Miller, Sarah E Soden, and Carol J Saunders.
• Children's Mercy Hospital & Clinics, 2401 Gillham Road, Kansas City, MO 64108, USA. sfkingsmore@cmh.edu
• Expert Rev. Mol. Diagn. 2011 Nov 1; 11 (8): 855-68.

AbstractOrphan diseases are individually uncommon but collectively contribute significantly to pediatric morbidity, mortality and healthcare costs. Current molecular testing for rare genetic disorders is often a lengthy and costly endeavor, and in many cases a molecular diagnosis is never achieved despite extensive testing. Diseases with locus heterogeneity or overlapping signs and symptoms are especially challenging owing to the number of potential targets. Consequently, there is immense need for scalable, economical, rapid, multiplexed diagnostic testing for rare Mendelian diseases. Recent advances in next-generation sequencing and bioinformatic technologies have the potential to change the standard of care for the diagnosis of rare genetic disorders. These advances will be reviewed in the setting of a recently developed test for 592 autosomal recessive and X-linked diseases.

21 keywords...

hide…